Enlarged Prostate ( BPH, Benign Prostatic Hyperplasia)
Title: Enlarged Prostate ( BPH, Benign Prostatic Hyperplasia)Category: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 5/18/2017 12:00:00 AM (Source: MedicineNet Mens Health General)
Source: MedicineNet Mens Health General - May 18, 2017 Category: Primary Care Source Type: news
MassDevice.com +5 | The top 5 medtech stories for May 17, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. 10 innovative diagnostic tests to combat diseases
Medtech is seeing new exciting developments in the field of medical diagnostics, with recent innovations allowing for faster disease diagnosis than ever before. We cover 10 diag...
Source: Mass Device - May 17, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news
NeoTract touts 5-year UroLift study data
NeoTract today presented 5-year results from the pivotal Lift IDE study of its UroLift system, touting rapid reduction of symptoms and sustained effects in treating patients with symptomatic benign prostatic hyperplasia.
The UroLift system for benign prostate hyperplasia uses tiny devices that are inserted into the urethra in a minimally invasive procedure to reopen the lower urinary tract by pushing aside tissue from the enlarged prostate.
The 5-year results were presented by Dr. Claus Roehrborn of Dallas’ UT Southwestern Medical Center at the 112th annual American Urological Association meeting in Boston.
Resu...
Source: Mass Device - May 16, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Urology NeoTract Source Type: news
7 medtech stories we missed this week: May 12, 2017
[Image from unsplash.com]From Bioness’s new distribution deal to InBrace’s launch of new braces technology, here are 7 medtech stories we missed this week but thought were still worth mentioning.
1. Obalon receives approval to commercialize in Middle East
Obalon Therapeutics announced in a May 11 press release that it has received regulatory approvals in select Middle East markets to commercialize its 6-month, gas-filled intragastric balloon system. The FDA-approved, swallowable balloon system is designed to treat obesity and is the first and only system of its kind. The regulatory approval also accounts for it...
Source: Mass Device - May 12, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Business/Financial News Patient Monitoring Regulatory/Compliance Research & Development Surgical Bioness Inc. InBrace LensAR Inc. MedTech Obalon Therapeutics Ottobock SRS Medical Teleon Surgical ZipLine Medical Source Type: news
7 medtech stories we missed this week: March 31, 2017
[Image from unsplash.com]This week we saw a few FDA 510(k) clearances and one of the 1st uses of a next-generation surgical robot in Asia.
Here are 7 medtech stories we missed this week but thought were still worth mentioning:
1. Corindus touts first Asian use of next-generation robot
Corindus Vascular Robotics announced in a March 31 press release that robot-assisted PCI procedures were performed for the first time in Asia using the CorPath GRX system. The procedures were performed at Fu Wai Hospital. This is the first time the system has been used outside of the U.S. CorPath GRX enhances the precision and workflow of the...
Source: Mass Device - March 31, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Clinical Trials Food & Drug Administration (FDA) Robot-Assisted Surgery Robotics Stent Grafts Amniox Bodycad Corindus Endologix MedTech NeoSurgical NeoTract Providence Medical Tissuetech Source Type: news
Revolutionary UroLift(R) System Launches in Ireland
Innovative UroLift System to Treat Enlarged Prostate ready for roll out to Irish patients nationally
PLEASANTON, California, March 23, 2017 -- (Healthcare Sales & Marketing Network) -- NeoTract, Inc., announced today that the largest private health ins... Devices, Urology, Product Launch NeoTract, UroLift, Benign Prostatic Hyperplasia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 23, 2017 Category: Pharmaceuticals Source Type: news
NxThera raises $15 million
NxThera has raised $14.6 million in a new round of debt financing, according to an SEC filing posted this week.
The Maple Grove, Minn.-based company is offering convertible promissory notes and Series C preferred stock warrants in the round, according to the filing, with the 1st sale noted on Jan. 13.
NxThera is looking to raise an additional $809,831 in the round, and noted on the SEC filing that the amount sold does not include foreign purchasers. The company has not yet stated how it plans to spend funds raised in the round.
In Dec. 2015, NxThera said that Boston Scientific (NYSE:BSX) led a $40 million funding roun...
Source: Mass Device - March 3, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News NxThera Inc. Source Type: news
What Every Man Must Know About BPH
One of the most common conditions a man can get affecting his prostate is benign prostatic hyperplasia or BPH. BPH is an enlargement of the prostate putting pressure on the urethra making it difficult to urinate along with other symptoms associated with it.
It becomes more prevalent as a man ages with the risk of BPH increasing each year after a man turns 40. By age 60, more than half of all men will have BPH and by age 85, about 90 percent of men have this condition.
How will a man know if he has BPH?
Most of the signs and symptoms of BPH are urinary related. The prostate gland, the size of a walnut, surrounds the urethra...
Source: Healthy Living - The Huffington Post - February 28, 2017 Category: Consumer Health News Source Type: news
NxThera raises $12.2m
NxThera raised $12.2 million in a new round of financing, according to an SEC filing posted this week.
Funds in the round come through the offering of debt, warrants, convertible promissory notes and Series C preferred stock warrants, according to the filing.
Funds in the round were raised by 28 unnamed US purchasers, according to the SEC filing, and the company has not yet stated how it plans to use funds raised.
Last December, NxThera said that Boston Scientific (NYSE:BSX) led a $40 million funding round for its Rezūm device, saying it plans to boost its sales footprint in the U.S. and Europe.
Existing backers Aber...
Source: Mass Device - February 3, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News NxThera Inc. Source Type: news
Guidelines for the Treatment of Benign Prostatic Hyperplasia Guidelines for the Treatment of Benign Prostatic Hyperplasia
This article presents an overview of the many therapeutic options for benign prostatic hyperplasia, including lifestyle modifications, pharmacotherapy, and surgical interventions.U.S. Pharmacist (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 3, 2017 Category: Consumer Health News Tags: Urology Journal Article Source Type: news
Dr. David Samadi Explains Why Enlargement Of The Prostate Is More...
Dr. David Samadi gives his opinion on a recent retrospective cohort study out of Korea on findings showing benign prostatic hyperplasia is more likely to develop in men having a high body mass index...(PRWeb January 24, 2017)Read the full story at http://www.prweb.com/releases/David_Samadi/BPH/prweb14004896.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - January 24, 2017 Category: Pharmaceuticals Source Type: news
Medical News Today: Benign Prostatic Hyperplasia: Treatment, Symptoms, and Causes
What is BPH and what are the causes and risk factors? Learn about its diagnosis, complications, medication that may be used, and tips for living with BPH. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 4, 2017 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news
unctional Autoantibodies May Promote BPH unctional Autoantibodies May Promote BPH
Overstimulation by autoantibodies targeting the endothelin A receptor (ETA-AABs) may play a role in the development of benign prostatic hyperplasia (BPH), new research suggests.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - December 16, 2016 Category: Pathology Tags: Urology News Source Type: news
Functional Autoantibodies May Promote BPH Functional Autoantibodies May Promote BPH
Overstimulation by autoantibodies targeting the endothelin A receptor (ETA-AABs) may play a role in the development of benign prostatic hyperplasia (BPH), new research suggests.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - December 16, 2016 Category: Pathology Tags: Urology News Source Type: news
Prostatic Urethral Lift Relieves BPH Symptoms Prostatic Urethral Lift Relieves BPH Symptoms
The prosthetic urethral lift (PUL) procedure relieves lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH), researchers report.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 29, 2016 Category: Surgery Tags: Urology News Source Type: news
